Showing results (231-240 of 483) with videos related to
Sort By:
Pageof 49
Nature Genetics|December 3, 2013
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaHelen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, et al.International Journal of Cancer|April 25, 2022
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndromeKatie Watts, Christopher Wills, Ayman Madi, et al.International Journal of Cancer|May 27, 2010
Allergy and glioma risk: test of association by genotypeSara E Dobbins, Fay J Hosking, Sanjay Shete, et al.Blood|March 17, 2010
Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia riskFay J Hosking, Elli Papaemmanuil, Eammon Sheridan, et al.International Journal of Cancer|July 9, 2020
Prediction of colorectal cancer risk based on profiling with common genetic variantsXue Li, Maria Timofeeva, Athina Spiliopoulou, et al.Cancer Research|February 28, 2002
Low-level microsatellite instability in most colorectal carcinomasPäivi Laiho, Virpi Launonen, Päivi Lahermo, et al.Nature Genetics|September 2, 2008
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMaria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, et al.Nature Communications|November 25, 2016
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expressionNi Li, David C Johnson, Niels Weinhold, et al.Oncogene|March 16, 2002
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancerTimothy R Porter, Frances M Richards, Richard S Houlston, et al.Leukemia & Lymphoma|April 21, 2011
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrenceMonica Else, Claire E Dearden, Estella Matutes, et al.Pageof 49